The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 25 07 2018
accepted: 30 01 2019
entrez: 15 2 2019
pubmed: 15 2 2019
medline: 21 11 2019
Statut: epublish

Résumé

To investigate the association between current CD4+ T-cell count and CD4/CD8+ ratio with severity of frailty among people aging with HIV. Cross-sectional observational study analysing data from all study visits in the ongoing prospective Modena HIV Metabolic Clinic Cohort between 2006 and 2015. Frailty severity was assessed using a frailty index (FI). We visualized the relationships between frailty index score and current CD4 cell count and CD4/CD8 ratio on two different curves adjusted for age, sex, and duration of HIV infection. Frailty index scores exhibited an inverse relationship with current CD4 count, up to 900 cells/μL. The CD4/CD8 ratio was inversely correlated with frailty index both below and above the cut-off of 900 CD4 cells/μL. Frailty in PLWH is inversely associated with both immune-activation, depicted by CD4/CD8 ratio and immune-deficit depicted by CD4 count. The first association shows a linear shape while the second shows a hook-shape with a turning point at 900 cells. Above this cut off level CD4 do not represent a significant risk factor for frailty.

Identifiants

pubmed: 30763363
doi: 10.1371/journal.pone.0212283
pii: PONE-D-18-22052
pmc: PMC6375603
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0212283

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Womens Health (Larchmt). 2009 Dec;18(12):1965-74
pubmed: 20044858
J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):299-306
pubmed: 19194312
HIV Med. 2017 Nov;18(10):764-771
pubmed: 28737297
Clin Infect Dis. 2013 Oct;57(7):1038-47
pubmed: 23921881
BMC Geriatr. 2013 Jun 21;13:64
pubmed: 23786540
HIV Med. 2014 Jan;15(1):40-9
pubmed: 24007533
AIDS. 2015 Aug 24;29(13):1633-41
pubmed: 26372273
Curr Opin HIV AIDS. 2014 Jul;9(4):412-8
pubmed: 24840060
AIDS. 2014 Jan 14;28(2):187-99
pubmed: 24361680
J Gerontol A Biol Sci Med Sci. 2015 Dec;70(12):1533-41
pubmed: 26297938
HIV Clin Trials. 2006 May-Jun;7(3):97-106
pubmed: 16880166
Curr HIV/AIDS Rep. 2010 Feb;7(1):4-10
pubmed: 20425052
J Infect Dis. 2013 Jul 15;208(2):249-59
pubmed: 23559466
Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
AIDS. 2013 Jun 1;27(9):1513-6
pubmed: 23435292
N Engl J Med. 2015 Aug 27;373(9):795-807
pubmed: 26192873
JAMA Intern Med. 2013 Apr 22;173(8):614-22
pubmed: 23459863
PLoS Pathog. 2014 May 15;10(5):e1004078
pubmed: 24831517
J Infect. 2009 Nov;59(5):346-52
pubmed: 19706308
Clin Infect Dis. 2011 Dec;53(11):1120-6
pubmed: 21998278
J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):43-51
pubmed: 23018372
AIDS. 2016 Jan;30(2):241-50
pubmed: 26684821
Interdiscip Top Gerontol. 2015;40:85-98
pubmed: 25341515
Annu Rev Med. 2011;62:141-55
pubmed: 21090961
J Gerontol A Biol Sci Med Sci. 2015 Dec;70(12):1542-7
pubmed: 26386010
J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):e78-81
pubmed: 23666141
AIDS. 2014 May 15;28(8):1193-202
pubmed: 24556869
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
N Engl J Med. 2013 Jan 17;368(3):218-30
pubmed: 23323898
J Infect Dis. 2014 Oct 15;210(8):1170-9
pubmed: 24903667
Lancet. 2013 Nov 2;382(9903):1525-33
pubmed: 24152939
J Infect. 2013 Jan;66(1):57-66
pubmed: 23046968
J Gerontol A Biol Sci Med Sci. 2014 Feb;69(2):189-98
pubmed: 24127428
PLoS One. 2013;8(1):e54910
pubmed: 23382997
PLoS One. 2014 Jan 30;9(1):e85798
pubmed: 24497929
BMC Med. 2013 Nov 27;11:251
pubmed: 24283830
Lancet. 2015 Feb 14;385(9968):e7-e9
pubmed: 25468154
Clin Infect Dis. 2010 Aug 15;51(4):435-47
pubmed: 20597691
J Gerontol A Biol Sci Med Sci. 2014 Jul;69(7):833-42
pubmed: 24158766
Biogerontology. 2010 Oct;11(5):547-63
pubmed: 20559726
J Int Assoc Provid AIDS Care. 2013 Jan-Feb;12(1):62-6
pubmed: 23042791

Auteurs

Giovanni Guaraldi (G)

Infectious Diseases Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Stefano Zona (S)

Infectious Diseases Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Ana Rita Silva (AR)

Department of Infectious Diseases, Hospital Beatriz Ângelo, Loures, Portugal.

Marianna Menozzi (M)

Infectious Diseases Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Giovanni Dolci (G)

Infectious Diseases Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Jovana Milic (J)

Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.

Federica Carli (F)

Infectious Diseases Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Cristina Mussini (C)

Infectious Diseases Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH